Differential vitreous dye diffusion following microplasmin or plasmin pre-treatment

Current Eye Research

Volumn 35, Issue 3, 2010, Pages 235-241

  Gad Elkareem, Ashraf M ^a,b   Willikens, Ben ^c   Stassen, Jean Marie ^d   De Smet, Marc D ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Center for Specialized Ophthalmology   (Switzerland)

^c NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^d ThromboGenics NV   (Belgium)

Author keywords

Fluorescein diffusion; Gel electrophoresis; Microplasmin; Pharmacologic vitreolysis; Plasmin

Indexed keywords

ENZYME; FLUORESCEIN; MICROPLASMIN; PLASMIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIFFUSION; ELECTRON MICROSCOPY; ENZYME ACTIVITY; GEL ELECTROPHORESIS; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SWINE; TISSUE STRUCTURE; VITREOUS BODY;

ANIMALS; DIFFUSION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FIBRINOLYSIN; FIBRINOLYTIC AGENTS; FLUORESCEIN; FLUORESCENT DYES; MICROSCOPY, ELECTRON, SCANNING; PEPTIDE FRAGMENTS; SWINE; VITREOUS BODY;

EID: 77950793659     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713680903484259     Document Type: Article

References (30)

1. Sebag J. Anomalous posterior vitreous detachment: A unifying concept in vitreo-retinal disease. Graefe's Arch Clin Exp Ophthalmol 2004;242:690-698. (Pubitemid 39242846)
2. Akiba J, Arzabe CW, Trempe CL. Posterior vitreous detachment and neovascularization in diabetic retinopathy. Ophthalmol 1990;97:889-891. (Pubitemid 20217938)
3. Akiba J, Quiroz MA, Trempe CL. Role of posterior vitreous detachment in idiopathic macular holes. Ophthalmol 1990;97:1610-1613.
4. Chu TG, lopez PF, Cano MR, et al. Posterior vitreoschisis. An echographic finding in proliferative diabetic retinopathy. Ophthalmol 1996;103:315-322.
5. Sarrafizadeh R, Hassan TS, Ruby AJ, et al. Incidence of retinal detachment and visual outcome in eyes presenting with posterior vitreous separation and dense fundus-obscuring vitreous hemorrhage. Ophthalmol 2001;108:2273-2278. (Pubitemid 33096942)
6. Sebag J. Anatomy and pathology of the vitreoretinal interface. Eye 1992;6:541-552.
7. Sebag J. Is pharmacologic vitreolysis brewing? Retina 2002;22:1-3.
8. Kuppermann BD, Thomas EL, de Smet MD, et al. The Vitrase for Vitreous Hemorrhage Study Groups. Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage. Am J Ophthalmol 2005;140:573-584. (Pubitemid 41455296)
9. Oliveira LB, Tatebayashi M, Mahmoud TH, et al. Dispase facilitates posterior vitreous detachment during vitrectomy in young pigs. Retina 2001;21:342-1331 (Pubitemid 32769245)
10. Staubach F, Nober V, Janknecht P. Enzyme-assisted vitrectomy in enucleated pig eyes: A comparison of hyaluronidase, chondroitinase, and plasmin. Curr Eye Res 2004;29:261-268. (Pubitemid 40095009)
11. Tripathi RC, Tripathi BJ, Park JK, et al. Intracameral tissue plasminogen activator for resolution of fibrin clots after glaucoma filtering procedures. Am J Ophthalmol 1991;111:247-248.
12. Wang F, Wang Z, Sun X, et al. Safety and efficacy of dispase and plasmin in pharmacologic vitreolysis. Invest Ophthalmol Vis Sci 2004;45:3296-13290 (Pubitemid 39121868)
13. Pluen A, Netti PA, Jain RK, et al. Diffusion of macromolecules in agarose gels: Comparison of linear and globular configurations. Biophys J 1999;77:542-562. (Pubitemid 29305250)
14. Johnson EM, Berk DA, Jain RK, et al. Hindered diffusion in agarose gels: Test of effective medium model. Biophys J 1996;70:1017-1026.
15. Kim H, Robinson SM, Csaky KG. Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina. Pharmaceutical Research. 2009;26:329-337.
16. Castellino FJ, Ploplis VA.Human plasminogen: Structure, activation, and function. In: DM Waisman (Ed.). Plasminogen: Structure, Activation, and Regulation. Dordrecht, Netherlands: Kluwer Academic/Plenum Publishers, 2003;pp. 3-17.
17. Ma Z, Lu W, Wu S, et al. Expression and characterization of recombinant human micro-plasminogen. Biotechnol Lett 2007;29:517-523. (Pubitemid 46384892)
18. Nagai N, Demarsin E, Van Hoef B, et al. Recombinant human microplasmin: Production and potential therapeutic properties. J Thrombosis & Haemostasis 2003; 1:307-313.
19. Shi GY, Wu HL. Isolation and characterization of microplasminogen: A low molecular weight form of plasminogen. J Biol Chem 1988;263:17071-17075.
20. de Smet MD, Gandorfer A, Stalmans P, et al. Microplasmin intravitreal administration in patients with vitreomacular traction scheduled for vitrectomy: The MIVI I trial. Ophthalmol 2009;116:1349-1355.
21. de Smet MD, Valmaggia C, Zarrantz J, et al. Microplasmin: Ex vivo characterization of its activity in porcine vitreous. Invest Ophthalmol Vis Sci 2009;50:814-819.
22. Bhisitkul RB. Anticipation for enzymatic vitreolysis. Br J Ophthalmol 2001;85:1-3.
23. Trese MT. Enzymatic vitreous surgery. Semin Ophthalmol 2000;15:116-121.
24. Trese MT, Williams GA, Hartzer MK. A new approach to stage 3 macular holes. Ophthalmol 2000; 107:1607-1611.
25. Stefánsson E. Physiology of vitreous surgery. Graefe's Arch Clin Experimental Ophthalmol 2009;247:147-163.
26. Tojo K. A pharmacokinetic model for ocular drug delivery. Chem & Pharmaceut Bull 2004;52:1290-1294. (Pubitemid 41364444)
27. Tojo K, Isowaki A. Pharmacokinetic model for in vivo/in vitro correlation of intravitreal drug delivery. Adv Drug Deliv Rev 2001;52:17-24. (Pubitemid 32973635)
28. Verstraeten TC, Chapman C, Hartzer M, et al. Pharmacologic induction of posterior vitreous detachment in the rabbit. Arch Ophthalmol 1993;111:849-854. (Pubitemid 23170602)
29. Sebag J, Ansari R, Suh K. Pharmacologic vitreolysis with microplasmin increases vitreous diffusion coefficients. Graefe's Arch Clin and Experimental Ophthalmol 2007;245:576-580. (Pubitemid 46477319)
30. Mukai, N, Nakanishi T, Shimizu A, et al. Identification of phosphotyrosyl proteins in vitreous humours of patients with vitreoretinal diseases by sodium dodecyl sulphatepolyacrylamide gel electrophoresis/Western blotting/ matrix-assisted laser desorption time-of-flight mass spectrometry. Ann Clin Biochem 2008;45:307-312. (Pubitemid 351724568)